Cancer

Disease

Treatment

ROKiT Pharma announced today it is rapidly progressing through final preclinical studies and moving forward with preparation for the initiation of a Phase 1b/2 clinical trial of ROK-001, a potentially low toxicity cancer drug derived from natural ingredients.
APRIL 2, 2020

Unleashing Nature

to
  • HEAL

  • INNOVATE

  • GIVE LIFE

  • DISCOVER

contact@rokitpharma.com

Rokit Pharma
9320 Deering Ave
Chatsworth, CA 91311
chevron-upquote-left